Bladder cancer early warning? new study banks blood and urine for future tests

NCT ID NCT06109857

Recruiting now Knowledge-focused Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study from Mayo Clinic is collecting blood and urine samples from 1,500 people with bladder cancer. The goal is to use these samples to develop simple, non-invasive tests that could detect bladder cancer earlier. Participants provide samples once, and no experimental treatments are given.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to simple blood or urine tests that catch bladder cancer earlier, when it's easier to treat.
What could go wrong: This is an observational study, not a treatment trial. It only collects samples for future research, so there is no direct benefit to participants and no guarantee a test will be developed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER CARCINOMA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Mayo Clinic in Rochester
RECRUITING

Rochester, Minnesota, 55905, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.